- RBC Capital raised the price target on NVIDIA Corporation NVDA from $461 to $528. NVIDIA shares fell 0.8% to $481.46 in pre-market trading.
- Needham boosted the price target for Synopsys, Inc. SNPS from $175 to $215. Synopsys shares gained 4.7% to $207.50 in pre-market trading.
- Wedbush lifted the price target for Shake Shack Inc SHAK from $53 to $77. Shake Shack shares rose 2.9% to $55.50 in pre-market trading.
- Credit Suisse lowered Sarepta Therapeutics Inc SRPT price target from $185 to $167. Sarepta Therapeutics shares fell 1.4% to $146.63 in pre-market trading.
- Citigroup cut BioMarin Pharmaceutical Inc. BMRN price target from $148 to $86. BioMarin Pharmaceutical shares fell 2.3% to $74.99 in pre-market trading.
- RBC Capital boosted the price target for Lowe`s Companies Inc LOW from $165 to $188. Lowe`s shares fell 0.3% to $134.35 in pre-market trading.
- Wells Fargo cut Crown Castle International Corp CCI price target from $188 to $170. Crown Castle shares fell 0.7% to $161.55 in pre-market trading.
- Stifel boosted the price target for Momenta Pharmaceuticals, Inc. MNTA from $47 to $52.5. Momenta Pharmaceuticals shares fell 0.2% to $52.03 in pre-market trading.
- KeyBanc lifted the price target on Timken Co TKR from $60 to $68. Timken shares fell 0.6% to close at $54.01 on Wednesday.
- SVB Leerink raised the price target for Immunovant Inc IMVT from $26 to $34. Immunovant shares rose 1.1% to $31.39 in pre-market trading.
BMRNBiomarin Pharmaceutical Inc
$59.170.60%
Edge Rankings
Momentum
24.06
Growth
-
Quality
55.64
Value
58.83
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in